Companies / Israel
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
Sun Ups Stake In Taro
February 2008 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
In a move that BMI interprets as a signal that India's Sun Pharmaceutical Industries is growing impatient with opposition to its proposed acquisition of Israel's Taro Pharmaceutical Industries from some of Taro's major stakeholders, Sun has purchased the shares of a key opponent to the deal. The purchase of 3,712,557 Taro shares from Brandes Investment Partners, which was carried out through a subsidiary, will raise Sun's stake in Taro to